JPS6169773A - イソインドリノン誘導体 - Google Patents

イソインドリノン誘導体

Info

Publication number
JPS6169773A
JPS6169773A JP59193073A JP19307384A JPS6169773A JP S6169773 A JPS6169773 A JP S6169773A JP 59193073 A JP59193073 A JP 59193073A JP 19307384 A JP19307384 A JP 19307384A JP S6169773 A JPS6169773 A JP S6169773A
Authority
JP
Japan
Prior art keywords
compound
formula
acid
chloro
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59193073A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0254838B2 (https=
Inventor
Giichi Goto
義一 後藤
Yoshiaki Saji
佐治　美昭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP59193073A priority Critical patent/JPS6169773A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to US06/774,470 priority patent/US4695572A/en
Priority to DE8585306494T priority patent/DE3567210D1/de
Priority to EP85306494A priority patent/EP0174858B1/en
Priority to AT85306494T priority patent/ATE39693T1/de
Priority to CA000490715A priority patent/CA1304381C/en
Publication of JPS6169773A publication Critical patent/JPS6169773A/ja
Priority to US07/067,218 priority patent/US4778801A/en
Priority to JP1278108A priority patent/JPH02262578A/ja
Publication of JPH0254838B2 publication Critical patent/JPH0254838B2/ja
Priority to SG1051/91A priority patent/SG105191G/en
Priority to CS914080A priority patent/CS408091A3/cs
Priority to HK39/92A priority patent/HK3992A/xx
Priority to MX9203039A priority patent/MX9203039A/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP59193073A 1984-09-14 1984-09-14 イソインドリノン誘導体 Granted JPS6169773A (ja)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP59193073A JPS6169773A (ja) 1984-09-14 1984-09-14 イソインドリノン誘導体
US06/774,470 US4695572A (en) 1984-09-14 1985-09-10 Isoindolinone derivatives, production and use thereof
DE8585306494T DE3567210D1 (en) 1984-09-14 1985-09-12 Isoindolinone derivatives, production and use thereof
EP85306494A EP0174858B1 (en) 1984-09-14 1985-09-12 Isoindolinone derivatives, production and use thereof
AT85306494T ATE39693T1 (de) 1984-09-14 1985-09-12 Isoindolinonderivate, ihre herstellung und verwendung.
CA000490715A CA1304381C (en) 1984-09-14 1985-09-13 3-(piperidin-1-yl)-carbonylmethyl-isoindolin-1-one
US07/067,218 US4778801A (en) 1984-09-14 1987-06-29 Isoindolinone derivatives, production and use thereof
JP1278108A JPH02262578A (ja) 1984-09-14 1989-10-25 イソインドリノン誘導体
SG1051/91A SG105191G (en) 1984-09-14 1991-12-12 Isoindolinone derivatives,production and use thereof
CS914080A CS408091A3 (en) 1984-09-14 1991-12-27 Isoindoline derivatives, process of their preparation and application
HK39/92A HK3992A (en) 1984-09-14 1992-01-09 Isoindolinone derivatives,production and use thereof
MX9203039A MX9203039A (es) 1984-09-14 1992-06-19 Derivados de isoindolina y composicion farmaceutica que los contiene.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59193073A JPS6169773A (ja) 1984-09-14 1984-09-14 イソインドリノン誘導体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP1278108A Division JPH02262578A (ja) 1984-09-14 1989-10-25 イソインドリノン誘導体

Publications (2)

Publication Number Publication Date
JPS6169773A true JPS6169773A (ja) 1986-04-10
JPH0254838B2 JPH0254838B2 (https=) 1990-11-22

Family

ID=16301753

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59193073A Granted JPS6169773A (ja) 1984-09-14 1984-09-14 イソインドリノン誘導体

Country Status (10)

Country Link
US (2) US4695572A (https=)
EP (1) EP0174858B1 (https=)
JP (1) JPS6169773A (https=)
AT (1) ATE39693T1 (https=)
CA (1) CA1304381C (https=)
CS (1) CS408091A3 (https=)
DE (1) DE3567210D1 (https=)
HK (1) HK3992A (https=)
MX (1) MX9203039A (https=)
SG (1) SG105191G (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0602814A1 (en) * 1992-12-18 1994-06-22 Takeda Chemical Industries, Ltd. Crystal forms of optically active isoindolines and their use

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2607503B1 (fr) * 1986-12-02 1989-02-24 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2607504B1 (fr) * 1986-12-02 1989-01-27 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
US5102890A (en) * 1989-09-05 1992-04-07 Rhone-Poulenc Sante Pyrrole derivatives, their preparation and pharmaceutical compositions which contain them
EP0529778A1 (en) * 1991-07-10 1993-03-03 Takeda Chemical Industries, Ltd. Optically active isoindoline derivatives, their production and use
US5273978A (en) * 1991-07-10 1993-12-28 Takeda Chemical Industries, Ltd. Optically active isoindoline derivatives, their production and use
FR2687154B1 (fr) * 1992-02-07 1995-05-12 Rhone Poulenc Rorer Sa Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent.
FR2695389B1 (fr) * 1992-09-08 1994-11-04 Rhone Poulenc Rorer Sa Nouveau dérivé de l'isoindolinone, sa préparation et les compositions pharmaceutiques qui le contiennent.
GR1001497B (el) * 1992-10-08 1994-02-28 Takeda Chemical Industries Ltd Οπτικώς δραστικά ισοϊνδολινο παράγωγα, η παραγωγή και η χρησιμοποίηση αυτών.
US7937406B2 (en) * 2003-09-11 2011-05-03 Oracle America, Inc. Mechanism for automatically establishing a resource grid
CN117263909A (zh) * 2023-09-21 2023-12-22 常州大学 一种由亚砜叶立德制备异吲哚啉-1-酮的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58189163A (ja) * 1982-04-02 1983-11-04 Takeda Chem Ind Ltd 縮合ピロリノン誘導体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL34317A0 (en) * 1969-04-23 1970-06-17 Kabi Ab Substituted acetamides,their preparation and pharmaceutical compositions containing them
OA04285A (fr) * 1972-01-07 1979-12-31 Rhone Poulenc Sa Nouveaux dérivés de la pyrrolo (3,4-b) pyrazine et leur préparation.
US3966931A (en) * 1972-12-04 1976-06-29 Rhone-Poulenc S.A. 1,4-Dithino[2,3-c]pyrrole compositions
US4129729A (en) * 1978-01-03 1978-12-12 Monsanto Company 3-Phenacyl and phenacylidene phthalimidines and corresponding naphthoyl derivatives
SE7907121L (sv) * 1979-08-27 1981-02-28 Astra Laekemedel Ab Ftalimidinderivat
US4244966A (en) * 1979-09-24 1981-01-13 American Home Products Corporation 1,3-Dihydro-3-(2-hydroxy-, 2-bromo- or 2-chloroethyl)-2H-isoindol-1-one derivatives
EP0091241B1 (en) * 1982-04-02 1988-12-28 Takeda Chemical Industries, Ltd. Condensed pyrrolinone derivatives, and their production

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58189163A (ja) * 1982-04-02 1983-11-04 Takeda Chem Ind Ltd 縮合ピロリノン誘導体

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0602814A1 (en) * 1992-12-18 1994-06-22 Takeda Chemical Industries, Ltd. Crystal forms of optically active isoindolines and their use

Also Published As

Publication number Publication date
JPH0254838B2 (https=) 1990-11-22
US4695572A (en) 1987-09-22
EP0174858A1 (en) 1986-03-19
US4778801A (en) 1988-10-18
CS408091A3 (en) 1992-04-15
HK3992A (en) 1992-01-17
ATE39693T1 (de) 1989-01-15
DE3567210D1 (en) 1989-02-09
EP0174858B1 (en) 1989-01-04
SG105191G (en) 1992-02-14
CA1304381C (en) 1992-06-30
MX9203039A (es) 1992-07-01

Similar Documents

Publication Publication Date Title
JPH06507625A (ja) アンギオテンシンｉｉアンタゴニストとしての酸官能基を有する置換ピリミジノン
JPH05507092A (ja) ビス―ベンゾまたはベンゾピリドシクロヘプタピペリジン、ピペリジリデンおよびピペラジン化合物および組成物
PT1354884E (pt) Composto de ciclopenta (d) pirazolo [1,5-a] piramida como antagonista de receptor de crf
JPH0223537B2 (https=)
JPH0733385B2 (ja) 物質ｐの拮抗薬としてのｎ−アルキルキヌクリジニウム塩
WO1999043681A1 (en) 4-(4-piperidylmethylamino) substituted heteroaryl fused pyridines: gaba brain receptor ligands
KR19990028757A (ko) 벤조[ｇ]퀴놀린 유도체
US4299831A (en) 2-Trifluoromethyl-3-quinoline carboxamides, analgesic and anti-inflammatory compositions and methods employing them
JPS6169773A (ja) イソインドリノン誘導体
DE3853608T2 (de) Zyklische Anthranil-carbonsäurederivate und Verfahren zu deren Herstellung.
JPH06763B2 (ja) ベンゾ〔ｈ〕シンノリン誘導体
JPH01146879A (ja) アゼチジニルキノロンカルボン酸とそのエステル類
SE466656B (sv) Nya mellanprodukter anvaendbara foer framstaellning av 4-hydroxi-3-kinolinkarboxylsyraderivat
JPH0450313B2 (https=)
JPS6229585A (ja) エーテル化若しくはエステル化しうるジヒドロキシ基により位置２で置換された４―ｏｈキノリンカルボン酸の新規の誘導体、その製造方法、及び医薬としてのその使用
JP2744224B2 (ja) ビス−アザ−二環式抗不安薬の製法
JPS6019317B2 (ja) チエノチアジン誘導体及びその製造方法
JPH0342276B2 (https=)
JPH02262578A (ja) イソインドリノン誘導体
JPH10505330A (ja) ハロゲンイミダゾピリジン
JPS63295577A (ja) トリアゾロピリダジン誘導体
JPH04364180A (ja) イソインドリノン誘導体
JPS6176491A (ja) 新規なイソオキサゾロキノリン誘導体、製造のための方法および中間体、薬剤としての用途並びに薬剤含有組成物
US4608381A (en) Antiinflammatory 2-(trifluoroethylsulfonyl)benzimidazoles
KR810000718B1 (ko) 티아졸로[3,4-a] 인돌유도체의 제조방법